Home  > Resource Center  > News and Press Releases
July 19, 2015

Breakthrough global agreement sharply lowers price of early infant diagnosis of HIV

CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and consumables associated with diagnosing HIV in very young children. Learn more here.

Programs: HIV/AIDS

Related posts

HIV services are still falling. A year into the funding crisis, new data shows little recovery.
Lenacapavir and long-acting HIV PrEP: flash market update and spotlights across early adopters
Delivering integration under GC8: A toolkit to strengthen HIV outcomes through integration with hepatitis, harm reduction, and triple elimination
Market Memo: Integrated screening for triple elimination of HIV, syphilis, and hepatitis B
The 2025 HIV Market Report: The state of the HIV market in low- and middle-income countries
Dual HIV/Syphilis Rapid Tests: Lessons from Scale-Up Across Six Countries

Read more

HIV services are still falling. A year into the funding crisis, new data shows little recovery.
Lenacapavir and long-acting HIV PrEP: flash market update and spotlights across early adopters
Delivering integration under GC8: A toolkit to strengthen HIV outcomes through integration with hepatitis, harm reduction, and triple elimination
Browse Resource Center
Back To Top